MSME (Udyam registered) Ministry of MSME
- Category
- Small (2022-23)
- Udyam number
- UDYAM-KL-12-0000207
Remedex Pharma Private Limited - healthcare in Thiruvananthapuram, Kerala, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.44 Cr
▲ 4% YoY
Net profit · FY 2025
₹15 Lakh
Net margin 1.3%
EBITDA · FY 2025
₹1.04 Cr
EBITDA margin 9.1%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹8.74 Cr
Satisfied ₹1.4 Cr
Company age
10 yrs
Est. 2016
Directors on board
3
As per MCA filings
About Remedex Pharma Private Limited
Data last updated:
Remedex Pharma Private Limited is a private limited company based in Thiruvananthapuram, Kerala, India. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 07 November 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ernakulam, under CIN U74999KL2016PTC047213. Its GSTIN is 32AAICR0878G1ZC (Kerala).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Salman Mohammed Siddikh (Managing Director) and Aleemkhan Nisarudeen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Thiruvananthapuram, Kerala.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.44 Cr, a growth of 4% compared to the previous year. For the same year it recorded a net profit of ₹15 Lakh (net margin 1.3%) and EBITDA of ₹1.04 Cr (EBITDA margin 9.1%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 19% over five years.
The company is associated with 1 brand: Remidex Pharma. As per MCA filings, the company has open charges of ₹8.74 Cr and satisfied charges of ₹1.4 Cr on record.
Remedex Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-KL-12-0000207). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website remedexpharma.business.site.
Company details
CIN U74999KL2016PTC047213
Registration Number 047213
Incorporation Date 07 November 2016
ROC Ernakulam
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-KL-12-0000207
Key People
Salman Mohammed Siddikh Managing Director Aleemkhan Nisarudeen Director Shibin Lal Babu Kamalabai Director Recognitions & Rankings of Remedex Pharma
Contact details
Remedex Pharma Private Limited's registered office is in Thiruvananthapuram, Kerala. Its website is remedexpharma.business.site. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDoor No 2435/1, Ward No 16 Medical College Navarangam Lane, Thiruvananthapuram, Kerala, India – 695011
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Remedex Pharma Private Limited, buy the company report.
Comprehensive company report
Remedex Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Remedex Pharma operates one associated brand: Remidex Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures high-quality pharmaceutical and nutraceutical products, including tablets, capsules, liquids, and premixes. | remidexpharma.com |
Business activity
The main business activity of Remedex Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Remedex Pharma Private Limited, buy the company report.
Financials of Remedex Pharma Private Limited
FY 2025 filings availableRemedex Pharma Private Limited reported revenue of ₹11.44 Cr (up 4% YoY) for FY 2025.
Revenue · FY 2025
₹11.44 Cr ▲ 4%
Net profit · FY 2025
₹15 Lakh margin 1.3%
EBITDA · FY 2025
₹1.04 Cr margin 9.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 4%
3 years · compounded
▼ 2%
5 years · compounded
▲ 19%
EBITDA CAGR growth
1 year
▼ 3%
3 years · compounded
▼ 9%
Revenue has grown at a compounded annual rate (CAGR) of 19% over five years, including 4% growth in the latest year. EBITDA fell 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.04 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹15 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.1% | ||||
| Net Profit Margin | 1.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Remedex Pharma Private Limited, buy the company report.
Board of directors of Remedex Pharma Private Limited
Remedex Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Aleemkhan Nisarudeen | Director | 13 Nov 2019 | 6 Years 11 Months | Current |
| Shibin Lal Babu Kamalabai | Director | 23 Aug 2021 | 5 Years 2 Months | Current |
| Salman Mohammed Siddikh | Managing Director | 07 Nov 2016 | 9 Years 11 Months | Current |
Peer comparison
Remedex Pharma Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Genmed Shoppes Private Limited | ₹11.51 Cr (FY 2024) | 142.0% | Surat, Gujarat, India | |||
| Dermazone Pharmaceuticals Private Limited | ₹11.44 Cr (FY 2024) | 22.0% | Thane, Maharashtra, India | |||
| Saluja Medicose Private Limited | ₹11.44 Cr (FY 2025) | -1.0% | Delhi, India | |||
| Remedex Pharma Private Limitedthis company | ₹11.44 Cr (FY 2025) | ₹15 Lakh | 1.3% | 4.0% | Thiruvananthapuram, Kerala, India | |
| Fenestra Pharmaceuticals Private Limited | ₹11.43 Cr (FY 2025) | 3.0% | Bangalore, Karnataka, India | |||
| Yogi Kripa Medi Chem Private Limited | ₹11.4 Cr (FY 2025) | -30.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Remedex Pharma Private Limited, buy the company report.
Auditor
Remedex Pharma Private Limited is audited by UNNI KRISHNANGOPAKUMARSINDHU for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| UNNI KRISHNANGOPAKUMARSINDHU | FY 2023 | 242931 |
Shareholding
The shareholding of Remedex Pharma Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Remedex Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹8.74 Cr
Satisfied charges
₹1.4 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Oct 2023 | 100818067 | Hdfc Bank Limited | ₹3.11 Cr | Open | |
| 26 Sep 2019 | 100297345 | Others | ₹4.97 Cr | Open | |
| 29 Jan 2019 | 100237897 | Others | ₹65.98 Lakh | Open | |
| 18 Apr 2022 | 100564388 | Others | ₹90 Lakh | Satisfied | |
| 11 Jan 2021 | 100411656 | Axis Bank Limited | ₹50 Lakh | Satisfied |
To see the full charge records of Remedex Pharma Private Limited, buy the company report.
Total charge records: 5 View all charges
Legal cases
No court or tribunal cases involving Remedex Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Remedex Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Remedex Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 32AAICR0878G1ZC | Kerala | Active | 27 Oct 2017 |
To see the full GST registrations and return filing status of Remedex Pharma Private Limited, buy the company report.
Recent activity
Remedex Pharma Private Limited has 7 board changes on record since 2016: 3 appointments and 4 cessations. The latest: Moidu Mohammad ceased to be Director on 29 Jul 2022.
AGM
Remedex Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 310.60 Lakh registered on 30 Oct 2023 with Charge ID 100818067 was modified on 05 Aug 2025.
Filing
Remedex Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam.
Charges
A charge registered on 18 Apr 2022 via Charge ID 100564388 with Others was fully satisfied on 06 Dec 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 310.60 Lakh with Charge ID 100818067 was registered on 30 Oct 2023.
Ceased
Moidu Mohammad ceased to be Director.
Charges
A charge registered on 11 Jan 2021 via Charge ID 100411656 with Axis Bank Limited was fully satisfied on 11 Jul 2022.
Charges
A charge with Others amounted to Rs. 90.00 Lakh with Charge ID 100564388 was registered on 18 Apr 2022.
Appointed
Shibin Lal Babu Kamalabai was appointed as Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 50.00 Lakh with Charge ID 100411656 was registered on 11 Jan 2021.
Ceased
Thajudeen Habeeb Mohammed ceased to be Director.
Appointed
Aleemkhan Nisarudeen was appointed as Director.
6 earlier events are in the company report.
Frequently asked questions
Remedex Pharma is an active private limited company based in Thiruvananthapuram, Kerala, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 07 November 2016 (10+ years old) and is registered under CIN U74999KL2016PTC047213.
Remedex Pharma has 3 current directors:
- Salman Mohammed Siddikh - Managing Director
- Aleemkhan Nisarudeen - Director
- Shibin Lal Babu Kamalabai - Director
The latest financial statements of Remedex Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Remedex Pharma is 32AAICR0878G1ZC, registered in Kerala.
The CIN (Corporate Identification Number) of Remedex Pharma is U74999KL2016PTC047213. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Remedex Pharma was incorporated on 07 November 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ernakulam.
The peers of Remedex Pharma by revenue are Genmed Shoppes Private Limited, Dermazone Pharmaceuticals Private Limited, Saluja Medicose Private Limited, Fenestra Pharmaceuticals Private Limited, Yogi Kripa Medi Chem Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Moidu Mohammad ceased to be Director on 29 Jul 2022. Shibin Lal Babu Kamalabai was appointed as Director on 23 Aug 2021. Thajudeen Habeeb Mohammed ceased to be Director on 18 Nov 2019. Remedex Pharma has 7 board changes on record in total.
Yes, Remedex Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-KL-12-0000207).
Remedex Pharma can be reached through the website remedexpharma.business.site. Its registered office is in Thiruvananthapuram, Kerala, India.
The registered office of Remedex Pharma is at Door No 24351, Ward No 16 Medical College Navarangam Lane, Thiruvananthapuram, Kerala, India – 695011.